Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Michael Allen to Male

This is a "connection" page, showing publications Michael Allen has written about Male.

 
Connection Strength
  
 
 
0.357
  
  1. Catanach B, Betz ME, Tvrdy C, Skelding C, Brummett S, Allen MH. Implementing an Emergency Department Telephone Follow-Up Program for Suicidal Patients: Successes and Challenges. Jt Comm J Qual Patient Saf. 2019 11; 45(11):725-732.
    View in: PubMed
    Score: 0.029
  2. Allen MH, Citrome L, Pikalov A, Hsu J, Loebel A. Efficacy of lurasidone in the treatment of agitation: A post hoc analysis of five short-term studies in acutely ill patients with schizophrenia. Gen Hosp Psychiatry. 2017 07; 47:75-82.
    View in: PubMed
    Score: 0.024
  3. Boudreaux ED, Jaques ML, Brady KM, Matson A, Allen MH. The Patient Safety Screener: Validation of a Brief Suicide Risk Screener for Emergency Department Settings. Arch Suicide Res. 2017 Jan 02; 21(1):52-61.
    View in: PubMed
    Score: 0.022
  4. Boudreaux ED, Jaques ML, Brady KM, Matson A, Allen MH. The patient safety screener: validation of a brief suicide risk screener for emergency department settings. Arch Suicide Res. 2015; 19(2):151-60.
    View in: PubMed
    Score: 0.021
  5. Allen MH, Abar BW, McCormick M, Barnes DH, Haukoos J, Garmel GM, Boudreaux ED. Screening for suicidal ideation and attempts among emergency department medical patients: instrument and results from the Psychiatric Emergency Research Collaboration. Suicide Life Threat Behav. 2013 Jun; 43(3):313-23.
    View in: PubMed
    Score: 0.018
  6. Allen MH, Feifel D, Lesem MD, Zimbroff DL, Ross R, Munzar P, Spyker DA, Cassella JV. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011 Oct; 72(10):1313-21.
    View in: PubMed
    Score: 0.016
  7. Allen MH, Debann? M, Lazignac C, Adam E, Dickinson LM, Damsa C. Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study. Am J Psychiatry. 2011 Apr; 168(4):395-9.
    View in: PubMed
    Score: 0.016
  8. Allen MH. Acute nonpsychotic mania: first episode. CNS Spectr. 2009 Nov; 14(11 Suppl 11):3-6; discussion 12-4.
    View in: PubMed
    Score: 0.014
  9. Marangell LB, Dennehy EB, Miyahara S, Wisniewski SR, Bauer MS, Rapaport MH, Allen MH. The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD. J Affect Disord. 2009 Apr; 114(1-3):58-67.
    View in: PubMed
    Score: 0.013
  10. Migon MN, Coutinho ES, Huf G, Adams CE, Cunha GM, Allen MH. Factors associated with the use of physical restraints for agitated patients in psychiatric emergency rooms. Gen Hosp Psychiatry. 2008 May-Jun; 30(3):263-8.
    View in: PubMed
    Score: 0.013
  11. Damsa C, Adam E, Lazignac C, De Gregorio F, Mihai A, Lejeune J, Sarasin F, Allen MH. Intramuscular olanzapine in patients with schizophrenia: an observational study in an emergency room. Bull Soc Sci Med Grand Duche Luxemb. 2008; (2):209-16.
    View in: PubMed
    Score: 0.013
  12. Damsa C, Adam E, De Gregorio F, Cailhol L, Lejeune J, Lazignac C, Allen MH. Intramuscular olanzapine in patients with borderline personality disorder: an observational study in an emergency room. Gen Hosp Psychiatry. 2007 Jan-Feb; 29(1):51-3.
    View in: PubMed
    Score: 0.012
  13. Stuyt EB, Sajbel TA, Allen MH. Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders. Am J Addict. 2006 Mar-Apr; 15(2):166-73.
    View in: PubMed
    Score: 0.011
  14. Allen MH, Hirschfeld RM, Wozniak PJ, Baker JD, Bowden CL. Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania. Am J Psychiatry. 2006 Feb; 163(2):272-5.
    View in: PubMed
    Score: 0.011
  15. Allen MH, Chessick CA, Miklowitz DJ, Goldberg JF, Wisniewski SR, Miyahara S, Calabrese JR, Marangell L, Bauer MS, Thomas MR, Bowden CL, Sachs GS. Contributors to suicidal ideation among bipolar patients with and without a history of suicide attempts. Suicide Life Threat Behav. 2005 Dec; 35(6):671-80.
    View in: PubMed
    Score: 0.011
  16. Morris CD, Miklowitz DJ, Wisniewski SR, Giese AA, Thomas MR, Allen MH. Care satisfaction, hope, and life functioning among adults with bipolar disorder: data from the first 1000 participants in the Systematic Treatment Enhancement Program. Compr Psychiatry. 2005 Mar-Apr; 46(2):98-104.
    View in: PubMed
    Score: 0.010
  17. Alderfer BS, Allen MH. Treatment of agitation in bipolar disorder across the life cycle. J Clin Psychiatry. 2003; 64 Suppl 4:3-9.
    View in: PubMed
    Score: 0.009
  18. Goldman-Mellor SJ, Bhat HS, Allen MH, Schoenbaum M. Suicide Risk Among Hospitalized Versus Discharged Deliberate Self-Harm Patients: Generalized Random Forest Analysis Using a Large Claims Data Set. Am J Prev Med. 2022 04; 62(4):558-566.
    View in: PubMed
    Score: 0.008
  19. Reno E, Brown TL, Betz ME, Allen MH, Hoffecker L, Reitinger J, Roach R, Honigman B. Suicide and High Altitude: An Integrative Review. High Alt Med Biol. 2018 06; 19(2):99-108.
    View in: PubMed
    Score: 0.006
  20. Miller IW, Camargo CA, Arias SA, Sullivan AF, Allen MH, Goldstein AB, Manton AP, Espinola JA, Jones R, Hasegawa K, Boudreaux ED. Suicide Prevention in an Emergency Department Population: The ED-SAFE Study. JAMA Psychiatry. 2017 06 01; 74(6):563-570.
    View in: PubMed
    Score: 0.006
  21. Boudreaux ED, Camargo CA, Arias SA, Sullivan AF, Allen MH, Goldstein AB, Manton AP, Espinola JA, Miller IW. Improving Suicide Risk Screening and Detection in the Emergency Department. Am J Prev Med. 2016 Apr; 50(4):445-453.
    View in: PubMed
    Score: 0.005
  22. Arias SA, Miller I, Camargo CA, Sullivan AF, Goldstein AB, Allen MH, Manton AP, Boudreaux ED. Factors Associated With Suicide Outcomes 12 Months After Screening Positive for Suicide Risk in the Emergency Department. Psychiatr Serv. 2016 Feb; 67(2):206-13.
    View in: PubMed
    Score: 0.005
  23. Kwentus J, Riesenberg RA, Marandi M, Manning RA, Allen MH, Fishman RS, Spyker DA, Kehne JH, Cassella JV. Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine. Bipolar Disord. 2012 Feb; 14(1):31-40.
    View in: PubMed
    Score: 0.004
  24. Ting SA, Sullivan AF, Miller I, Espinola JA, Allen MH, Camargo CA, Boudreaux ED. Multicenter study of predictors of suicide screening in emergency departments. Acad Emerg Med. 2012 Feb; 19(2):239-43.
    View in: PubMed
    Score: 0.004
  25. Dennehy EB, Marangell LB, Allen MH, Chessick C, Wisniewski SR, Thase ME. Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Affect Disord. 2011 Oct; 133(3):423-7.
    View in: PubMed
    Score: 0.004
  26. Lesem MD, Tran-Johnson TK, Riesenberg RA, Feifel D, Allen MH, Fishman R, Spyker DA, Kehne JH, Cassella JV. Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. Br J Psychiatry. 2011 Jan; 198(1):51-8.
    View in: PubMed
    Score: 0.004
  27. Mihai A, Allen MH, Beezhold J, Rosu C, Nirestean A, Damsa C. Are female psychiatry residents better to propose in emergency a voluntary hospitalization? Psychiatr Q. 2009 Dec; 80(4):233-9.
    View in: PubMed
    Score: 0.004
  28. Chessick CA, Perlick DA, Miklowitz DJ, Dickinson LM, Allen MH, Morris CD, Gonzalez JM, Marangell LB, Cosgrove V, Ostacher M. Suicidal ideation and depressive symptoms among bipolar patients as predictors of the health and well-being of caregivers. Bipolar Disord. 2009 Dec; 11(8):876-84.
    View in: PubMed
    Score: 0.004
  29. Mansour HA, Talkowski ME, Wood J, Chowdari KV, McClain L, Prasad K, Montrose D, Fagiolini A, Friedman ES, Allen MH, Bowden CL, Calabrese J, El-Mallakh RS, Escamilla M, Faraone SV, Fossey MD, Gyulai L, Loftis JM, Hauser P, Ketter TA, Marangell LB, Miklowitz DJ, Nierenberg AA, Patel J, Sachs GS, Sklar P, Smoller JW, Laird N, Keshavan M, Thase ME, Axelson D, Birmaher B, Lewis D, Monk T, Frank E, Kupfer DJ, Devlin B, Nimgaonkar VL. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord. 2009 Nov; 11(7):701-10.
    View in: PubMed
    Score: 0.004
  30. Marangell LB, Dennehy EB, Wisniewski SR, Bauer MS, Miyahara S, Allen MH, Martinez M, Al Jurdi RK, Thase ME. Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD. J Clin Psychiatry. 2008 Jun; 69(6):916-22.
    View in: PubMed
    Score: 0.003
  31. Schneck CD, Miklowitz DJ, Miyahara S, Araga M, Wisniewski S, Gyulai L, Allen MH, Thase ME, Sachs GS. The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2008 Mar; 165(3):370-7; quiz 410.
    View in: PubMed
    Score: 0.003
  32. Chessick CA, Perlick DA, Miklowitz DJ, Kaczynski R, Allen MH, Morris CD, Marangell LB. Current suicide ideation and prior suicide attempts of bipolar patients as influences on caregiver burden. Suicide Life Threat Behav. 2007 Aug; 37(4):482-91.
    View in: PubMed
    Score: 0.003
  33. Daniel DG, Currier GW, Zimbroff DL, Allen MH, Oren D, Manos G, McQuade R, Pikalov AA, Crandall DT. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations. J Psychiatr Pract. 2007 May; 13(3):170-7.
    View in: PubMed
    Score: 0.003
  34. Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007 Apr 26; 356(17):1711-22.
    View in: PubMed
    Score: 0.003
  35. Marangell LB, Bauer MS, Dennehy EB, Wisniewski SR, Allen MH, Miklowitz DJ, Oquendo MA, Frank E, Perlis RH, Martinez JM, Fagiolini A, Otto MW, Chessick CA, Zboyan HA, Miyahara S, Sachs G, Thase ME. Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years. Bipolar Disord. 2006 Oct; 8(5 Pt 2):566-75.
    View in: PubMed
    Score: 0.003
  36. Fossey MD, Otto MW, Yates WR, Wisniewski SR, Gyulai L, Allen MH, Miklowitz DJ, Coon KA, Ostacher MJ, Neel JL, Thase ME, Sachs GS, Weiss RD. Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants. Am J Addict. 2006 Mar-Apr; 15(2):138-43.
    View in: PubMed
    Score: 0.003
  37. Bauer MS, Wisniewski SR, Marangell LB, Chessick CA, Allen MH, Dennehy EB, Miklowitz DJ, Thase ME, Sachs GS. Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry. 2006 Jan; 67(1):48-55.
    View in: PubMed
    Score: 0.003
  38. Goldberg JF, Allen MH, Miklowitz DA, Bowden CL, Endick CJ, Chessick CA, Wisniewski SR, Miyahara S, Sagduyu K, Thase ME, Calabrese JR, Sachs GS. Suicidal ideation and pharmacotherapy among STEP-BD patients. Psychiatr Serv. 2005 Dec; 56(12):1534-40.
    View in: PubMed
    Score: 0.003
  39. Waxmonsky JA, Thomas MR, Miklowitz DJ, Allen MH, Wisniewski SR, Zhang H, Ostacher MJ, Fossey MD. Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program. Gen Hosp Psychiatry. 2005 Sep-Oct; 27(5):321-8.
    View in: PubMed
    Score: 0.003
  40. Zimbroff DL, Allen MH, Battaglia J, Citrome L, Fishkind A, Francis A, Herr DL, Hughes D, Martel M, Preval H, Ross R. Best clinical practice with ziprasidone IM: update after 2 years of experience. CNS Spectr. 2005 Sep; 10(9):1-15.
    View in: PubMed
    Score: 0.003
  41. Schneck CD, Miklowitz DJ, Calabrese JR, Allen MH, Thomas MR, Wisniewski SR, Miyahara S, Shelton MD, Ketter TA, Goldberg JF, Bowden CL, Sachs GS. Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. Am J Psychiatry. 2004 Oct; 161(10):1902-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)